MRI scans are strong diagnostics with high-definition images of what lies inside a body. Strong magnetic fields require precaution, as brought out by an instance where a young woman suffered very serious injuries due to an oversight in a metallic core within a silicone sex toy that she happened to have before the MRI scan. This makes a stark reminder about the potentially deadly consequences of missing metal objects when such procedures are being performed. In April 2023, a 23-year-old woman went into an MRI with a silicone plug containing a metal core that was not known.

She thought that the item is made entirely out of silicone according to the advertising. However, the strong magnetic field of the MRI machine interacted with the hidden metal, dragging the object through her body and causing excruciating pain. According to reports from the U.S. Food and Drug Administration (FDA), the scene was harrowing, with the woman screaming in agony and requiring immediate hospitalization. Despite pre-scan screenings, which are routine prior to a scan, the patient did not inform the facility that the object existed because he presumed it was purely non-metallic. This caused serious injuries that led to the patient's law suit against the manufacturer for deceitful misrepresentations of material content.

MRI machines employ magnets between 0.5 to 3 Tesla (T). This is thousands of times stronger than the Earth's magnetic field. The tremendous force causes ferromagnetic materials, like iron and nickel, to be magnetized quickly and become strongly attracted toward the magnet. Objects as small as hairpins or paper clips will accelerate at 40 miles per hour inside the magnetic field.

The force can lead to catastrophic injuries in items lodged within the body, such as metallic implants or foreign objects. Metallic cores within devices, like pacemakers or intrauterine devices, must be disclosed to radiologists to prevent such complications.

How Metal Objects Interact with MRI Fields?

On these claims, Dr. Adam Taylor, a specialist in human anatomy, weighed his words in a international health website and added that the distance away and mass of this object would increase its velocity towards that of sound, "The acceleration would be phenomenal, but with a metallic core, it can't go anywhere near supersonic speeds. As for the size, the magnetic acceleration to the internal soft tissues would ensure that there could be severe intracranial trauma."

The injuries inflicted in this case likely involved damage to major blood vessels, nerves, or organs, highlighting the devastating impact of even minor oversight during an MRI scan.

This is not an isolated case. There are documented cases of metallic objects causing serious damage during MRI scans with a 65-year-old man with schizophrenia swallowed metal objects, including sockets and a hinge pin. The powerful magnetic field during an MRI scan caused the objects to rupture his stomach, resulting in serious injuries.

A toddler who ingested 11 small magnets perforated his bowel while undergoing a scan, making his case unique. In another deadly but extremely rare incident, there have been people who hide a firearm on themselves during MRI procedures. Magnetic attraction can trigger a discharge in a weapon and has led to some fatal injuries.

These cases emphasize the very strong need for adequate screening and patient education prior to an MRI.

Preventing MRI-Related Incidents

Medical professionals have been trained to avoid risks. This is by properly screening a patient for metallic objects. In general, most pre-scan protocols include:

• Patients are interrogated about implants, recent surgery or exposures at work related to metals.
• Radiologists sometimes use handheld metal detectors to search for hidden items.
• People who work with metal, like welders or machinists, will need additional testing to detect microscopic metal fragments within soft tissues or eyes.

The case emphasizes the importance of product labeling by manufacturers, especially those products that are likely to unintentionally cause harm to health. The patient's assumption that her device was 100% silicone points to a larger problem in consumer markets with misinformation.

It also reminds the patients to report any possible dangers to the medical professionals, no matter how the objects look non-metallic. In sensitive cases, patients can request private discussions with healthcare providers to ensure safety without discomfort.

In the end, it is a joint effort from manufacturers, healthcare professionals, and patients that can prevent such tragedies. Manufacturers must ensure truthful marketing, while healthcare providers should educate patients about the dangers of metal objects in MRI settings. For patients, understanding the risks and actively participating in pre-scan disclosures can be lifesaving.

This young woman's experience is a sobering example of the unforeseen dangers posed by MRI machines when precautions are overlooked. It serves as a wake-up call to address gaps in patient awareness, medical protocols, and product transparency. By learning from this incident, the medical community and the public can work together to ensure MRI scans remain a safe and effective diagnostic tool.

Europe is enduring an unprecedented June heatwave, with temperatures reaching as high as 43.8°C and several countries breaking national records. The extreme weather has forced authorities to issue red alerts, restrict public activities, deploy cooling centers, limit alcohol sales and warn of worsening health risks.

France, Spain and the UK Break Temperature Records

France has been among the worst-hit countries. On June 24, it recorded its hottest day on record, with an average national temperature of 30.0°C, surpassing previous records set in July 2019 and August 2003, according to Météo-France. Temperatures peaked at 43.8°C in the western town of Pulluau, while overnight temperatures also set a new national record.

A record 58 French departments were placed under the highest-level red alert as officials warned of an elevated risk of forest fires amid worsening drought conditions. Forty people reportedly died in drowning accidents during the intense heat, UN News reported.

Spain also recorded its hottest June days on record on June 23 and 24, with temperatures exceeding 40°C in several locations.

In the UK, the Met Office issued a red extreme heat warning and reported a provisional June record of 36.1°C at Gosport in southern England.

Germany issued widespread red alerts, including for Bonn, Frankfurt and Cologne, while Swiss cities such as Geneva, Basel and Zurich were also placed under red alert.

WMO Warns of More Extreme Heat

Also read: Heatwave Linked To 212 Deaths In Spain: How Does Heat Impact Health?

According to the World Meteorological Organization (WMO), the heatwave is expected to spread across Western, Central and Southern Europe over the next two weeks. The agency said temperatures are forecast to remain between 3°C and 10°C above average, with daily highs exceeding 35°C across many areas and locally crossing 40°C.

The WMO also warned of more frequent "tropical nights," when temperatures remain above 20°C overnight, preventing the body from recovering from daytime heat.

Hospitals Under Pressure, Paris Restricts Alcohol Sales

The worsening conditions have disrupted healthcare services, with media reports saying hospitals have had to postpone critical imaging scans after sensitive equipment overheated. Cities have also opened emergency cooling centers to protect vulnerable residents.

In Paris, authorities have announced temporary bans on public alcohol consumption and takeaway alcohol sales to ease pressure on hospitals. Public drinking will be prohibited from noon to 7 a.m. over the weekend, while takeaway alcohol sales will be banned between 6 p.m. and 7 a.m. Licensed bars and restaurants are exempt.

French Prime Minister Sébastien Lecornu said the country's highest health alert level had been activated to boost hospital staffing and protect vulnerable people.

"We are reaching a saturation point in hospital facilities," said Paris police chief Patrice Faure, while speaking to local media.

Faure has also asked organizers of the Pride march and the Solidays music festival to cancel their events because of the continuing heatwave.

Read More: UK Met Office Warns of 'Pollen Bomb': What Hay Fever Patients Need to Know

Formula 1 Declares Heat Hazard

The extreme temperatures have also reached the sporting world. Formula 1's governing body, the FIA, has declared another "heat hazard" ahead of the Austrian Grand Prix weekend at Spielberg's Red Bull Ring, triggering additional measures to protect drivers, teams and spectators.

"Europe's savage heatwave has the fingerprints of the climate crisis all over it", said United Nations climate chief Simon Stiell. He has called for "a faster shift to renewables, protecting forests and boosting climate resilience".

The Ebola outbreak in the Democratic Republic of Congo continues to worsen, with cases rising to 1,155 and deaths climbing to 304, as per the latest government data.

The figures represent the total confirmed cases as of June 24, according to a situation report which documented 37 new cases and five new deaths in the previous 24 hours. Ituri, North Kivu and South Kivu remain the most affected provinces in Congo.

Experimental treatments

Also read: Ebola Outbreak: The Unique Symptoms Seen In Patients Infected With Bundibugyo

The US is now providing doses of an experimental Ebola treatment developed by Mapp Biopharmaceutical for clinical trials in Congo.

The experimental therapy, known as MBP134, was developed by San Diego-based Mapp Biopharmaceutical. While the US had previously kept its stockpile for potential use in exposed American citizens, it is now making doses available to support clinical research in Congo. This is the first time Washington has publicly committed stockpiled supplies of the treatment for a broader international trial.

According to the World Health Organization, researchers will test MBP134 both on its own and alongside the antiviral drug remdesivir, marketed as Veklury. Remdesivir became widely known during the COVID-19 pandemic and is being evaluated to see whether it can improve outcomes when combined with the antibody treatment.

Ebola: Scientists Lack Access To Virus Samples

The ongoing outbreak is being driven by the rare Bundibugyo strain, for which no approved vaccine or treatment exists. However, scientists racing to develop vaccines and therapies are hampered by the lack of a viable sample of the virus.

“There’s nothing like having the authentic isolate,” said Thomas Geisbert, Professor of microbiology and immunology at the University of Texas Medical Branch in Galveston, who helped develop previous Ebola vaccines, Bloomberg reported.

“Despite so many cases, the global scientific community has not obtained a clinical sample to isolate the virus for the needed animal challenge studies,” added Jennifer Serwanga, head of immunology at the Uganda Virus Research Institute, the report said.

Ebola: WHO Warns Spread to South Sudan

Further, as per a new WHO modelling study published in The Lancet, the growing Congo Ebola outbreak, which has already spread to Uganda, has a 70 per cent chance of reaching South Sudan soon.

The study combined epidemic modelling with spillover estimation to quantify regional risks associated with the 2026 Ituri outbreak using laboratory-confirmed case data from WHO Situation Reports (33 cases as of May 18, 2026, to 598 cases as of June 8, 2026), with projections extending 12 weeks from May 18 to Aug. 10, 2026. It also integrates operational preparedness considerations relevant for neighboring countries.

The report showed that even with the intensified response within DR Congo, uncertainty remains around reported case numbers due to the low rate of contact tracing.

“Sustained control nonetheless remains the primary determinant of regional risk: importation into Uganda is already established, and South Sudan must continue to reinforce infection prevention and control, rapid response capacity, and cross-border surveillance under International Health Regulations 2005,” said researchers from the WHO Regional Office for Africa, Nairobi, Kenya.

The report called for:

1. Enhanced surveillance at formal and informal points of entry to detect suspected cases early and prevent silent transmission.
2. Strengthen infection prevention and control (IPC) measures in front-line health facilities to reduce nosocomial transmission and protect health-care workers.
3. Train, equip, and pre-position rapid response teams for immediate deployment.

The United States is now providing doses of an experimental Ebola treatment developed by Mapp Biopharmaceutical for clinical trials in the Democratic Republic of Congo, where a growing outbreak of the Bundibugyo strain has infected more than 1,000 people and claimed over 250 lives. The decision marks a significant shift from the U.S. government's earlier stance, which limited access to the drug to Americans considered at high risk of exposure.

Health officials are racing to find effective ways to contain the outbreak, as there are currently no approved vaccines or treatments specifically designed for the Bundibugyo strain of Ebola. A small number of cases and deaths have also been reported in neighboring Uganda, raising concerns about the disease spreading further across the region.

The experimental therapy, known as MBP134, was developed by San Diego-based Mapp Biopharmaceutical. While the U.S. had previously kept its stockpile for potential use in exposed American citizens, it is now making doses available to support clinical research in Congo. This is the first time Washington has publicly committed stockpiled supplies of the treatment for a broader international trial.

According to the World Health Organization, researchers will test MBP134 both on its own and alongside the antiviral drug remdesivir, marketed as Veklury. Remdesivir became widely known during the COVID-19 pandemic and is being evaluated to see whether it can improve outcomes when combined with the antibody treatment.

Also Read: Nutritional Foods That Help Keep Cholesterol Under Control

Ebola Situation In Western Africa

The confirmed cases in the Ebola outbreak in the Democratic Republic of Congo (DRC) have reached the highest total ever recorded during the first month of an outbreak in Africa, according to the World Health Organization (WHO).

As of June 22, confirmed Ebola cases in Congo had risen to 1,094 and deaths to 277, according to the DRC Ministry of Health. The WHO raised concerns about the rapid spread of the deadly virus and the challenges facing containment efforts.

“This is the largest number of confirmed cases in the first month of an Ebola disease outbreak in Africa,” said Dr Abdirahman Mahamud, Director, Health Emergency Alert and Response Operations at WHO, during a press briefing in Geneva.

"What is important is we need to scale up and this outbreak is moving faster than us," he told reporters after returning from Bunia last week.

Mahamud also noted signs of hope, highlighting a quick increase in the number of Ebola beds to over 500 in the past fortnight and signs that community resistance and violent resistance to Ebola responders was beginning to abate.

As of June 24, Uganda had recorded 20 confirmed Ebola cases, including two fatalities. The latest infection was identified on June 21, with no additional cases reported afterward. Of the confirmed infections, 15 were linked to travel from the Democratic Republic of the Congo (DRC), while five resulted from local transmission. Among the nine cases with available location data, eight were detected in Kampala and one in the neighboring Wakiso District.